Cargando…
Comparing the Value of Data Visualization Methods for Communicating Harms in Clinical Trials
In clinical trials, harms (i.e., adverse events) are often reported by simply counting the number of people who experienced each event. Reporting only frequencies ignores other dimensions of the data that are important for stakeholders, including severity, seriousness, rate (recurrence), timing, and...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780120/ https://www.ncbi.nlm.nih.gov/pubmed/36065832 http://dx.doi.org/10.1093/epirev/mxac005 |
_version_ | 1784856776275918848 |
---|---|
author | Qureshi, Riaz Chen, Xiwei Goerg, Carsten Mayo-Wilson, Evan Dickinson, Stephanie Golzarri-Arroyo, Lilian Hong, Hwanhee Phillips, Rachel Cornelius, Victoria McAdams DeMarco, Mara Guallar, Eliseo Li, Tianjing |
author_facet | Qureshi, Riaz Chen, Xiwei Goerg, Carsten Mayo-Wilson, Evan Dickinson, Stephanie Golzarri-Arroyo, Lilian Hong, Hwanhee Phillips, Rachel Cornelius, Victoria McAdams DeMarco, Mara Guallar, Eliseo Li, Tianjing |
author_sort | Qureshi, Riaz |
collection | PubMed |
description | In clinical trials, harms (i.e., adverse events) are often reported by simply counting the number of people who experienced each event. Reporting only frequencies ignores other dimensions of the data that are important for stakeholders, including severity, seriousness, rate (recurrence), timing, and groups of related harms. Additionally, application of selection criteria to harms prevents most from being reported. Visualization of data could improve communication of multidimensional data. We replicated and compared the characteristics of 6 different approaches for visualizing harms: dot plot, stacked bar chart, volcano plot, heat map, treemap, and tendril plot. We considered binary events using individual participant data from a randomized trial of gabapentin for neuropathic pain. We assessed their value using a heuristic approach and a group of content experts. We produced all figures using R and share the open-source code on GitHub. Most original visualizations propose presenting individual harms (e.g., dizziness, somnolence) alone or alongside higher level (e.g., by body systems) summaries of harms, although they could be applied at either level. Visualizations can present different dimensions of all harms observed in trials. Except for the tendril plot, all other plots do not require individual participant data. The dot plot and volcano plot are favored as visualization approaches to present an overall summary of harms data. Our value assessment found the dot plot and volcano plot were favored by content experts. Using visualizations to report harms could improve communication. Trialists can use our provided code to easily implement these approaches. |
format | Online Article Text |
id | pubmed-9780120 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-97801202022-12-23 Comparing the Value of Data Visualization Methods for Communicating Harms in Clinical Trials Qureshi, Riaz Chen, Xiwei Goerg, Carsten Mayo-Wilson, Evan Dickinson, Stephanie Golzarri-Arroyo, Lilian Hong, Hwanhee Phillips, Rachel Cornelius, Victoria McAdams DeMarco, Mara Guallar, Eliseo Li, Tianjing Epidemiol Rev Review In clinical trials, harms (i.e., adverse events) are often reported by simply counting the number of people who experienced each event. Reporting only frequencies ignores other dimensions of the data that are important for stakeholders, including severity, seriousness, rate (recurrence), timing, and groups of related harms. Additionally, application of selection criteria to harms prevents most from being reported. Visualization of data could improve communication of multidimensional data. We replicated and compared the characteristics of 6 different approaches for visualizing harms: dot plot, stacked bar chart, volcano plot, heat map, treemap, and tendril plot. We considered binary events using individual participant data from a randomized trial of gabapentin for neuropathic pain. We assessed their value using a heuristic approach and a group of content experts. We produced all figures using R and share the open-source code on GitHub. Most original visualizations propose presenting individual harms (e.g., dizziness, somnolence) alone or alongside higher level (e.g., by body systems) summaries of harms, although they could be applied at either level. Visualizations can present different dimensions of all harms observed in trials. Except for the tendril plot, all other plots do not require individual participant data. The dot plot and volcano plot are favored as visualization approaches to present an overall summary of harms data. Our value assessment found the dot plot and volcano plot were favored by content experts. Using visualizations to report harms could improve communication. Trialists can use our provided code to easily implement these approaches. Oxford University Press 2022-09-18 /pmc/articles/PMC9780120/ /pubmed/36065832 http://dx.doi.org/10.1093/epirev/mxac005 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Review Qureshi, Riaz Chen, Xiwei Goerg, Carsten Mayo-Wilson, Evan Dickinson, Stephanie Golzarri-Arroyo, Lilian Hong, Hwanhee Phillips, Rachel Cornelius, Victoria McAdams DeMarco, Mara Guallar, Eliseo Li, Tianjing Comparing the Value of Data Visualization Methods for Communicating Harms in Clinical Trials |
title | Comparing the Value of Data Visualization Methods for Communicating Harms in Clinical Trials |
title_full | Comparing the Value of Data Visualization Methods for Communicating Harms in Clinical Trials |
title_fullStr | Comparing the Value of Data Visualization Methods for Communicating Harms in Clinical Trials |
title_full_unstemmed | Comparing the Value of Data Visualization Methods for Communicating Harms in Clinical Trials |
title_short | Comparing the Value of Data Visualization Methods for Communicating Harms in Clinical Trials |
title_sort | comparing the value of data visualization methods for communicating harms in clinical trials |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780120/ https://www.ncbi.nlm.nih.gov/pubmed/36065832 http://dx.doi.org/10.1093/epirev/mxac005 |
work_keys_str_mv | AT qureshiriaz comparingthevalueofdatavisualizationmethodsforcommunicatingharmsinclinicaltrials AT chenxiwei comparingthevalueofdatavisualizationmethodsforcommunicatingharmsinclinicaltrials AT goergcarsten comparingthevalueofdatavisualizationmethodsforcommunicatingharmsinclinicaltrials AT mayowilsonevan comparingthevalueofdatavisualizationmethodsforcommunicatingharmsinclinicaltrials AT dickinsonstephanie comparingthevalueofdatavisualizationmethodsforcommunicatingharmsinclinicaltrials AT golzarriarroyolilian comparingthevalueofdatavisualizationmethodsforcommunicatingharmsinclinicaltrials AT honghwanhee comparingthevalueofdatavisualizationmethodsforcommunicatingharmsinclinicaltrials AT phillipsrachel comparingthevalueofdatavisualizationmethodsforcommunicatingharmsinclinicaltrials AT corneliusvictoria comparingthevalueofdatavisualizationmethodsforcommunicatingharmsinclinicaltrials AT mcadamsdemarcomara comparingthevalueofdatavisualizationmethodsforcommunicatingharmsinclinicaltrials AT guallareliseo comparingthevalueofdatavisualizationmethodsforcommunicatingharmsinclinicaltrials AT litianjing comparingthevalueofdatavisualizationmethodsforcommunicatingharmsinclinicaltrials |